Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > A short math lesson...
View:
Post by gojotv! on Apr 06, 2021 7:13pm

A short math lesson...

Bashers keep whinging about the "3000 patients" we've acquired.
Hello?
The 3000 patients are not our market.
Our market is all the people you have to test to get 3000 patients.
With maybe up to 2% having actual cancer, you do the math!
Remember, this is a pre-symptomatictest.
Now do you get why the potential here is amazing?
And Health Clinics Ltd. has a stellar reputation for professionalism in oncology. They're going to get ALL the references from doctors in the region.
Those 51 employees will be kept very, very busy.
If they produce profits of just $20,000/head in the next quarter, that's $2.5M. But at the rate they're charging for Aristotle, profits will be much, much higher, IMHO.
Don't regret your "buys" over slander, bullying, and other signs of market churn.
Those who can add and subtract want your shares.
Comment by Eagles1968 on Apr 06, 2021 7:16pm
Sure man!
Comment by Eagles1968 on Apr 06, 2021 7:21pm
That's not it at all. They come to care oncology for treatment to take their cocktails of drugs to treat their cancer!
Comment by gojotv! on Apr 06, 2021 7:44pm
Hello? Before these patients came for care and cocktails, they came for tests, right? And many, many people were released when their tests came out negative, right? The 3000 are the people who tested positive and who are NOT our market. Get that into your head. Our market is the tens of thousands who want an easy, comprehensive, time-saving, no flattenned, irradiated breast, no snaking camera tube ...more  
Comment by Northerencents on Apr 06, 2021 7:23pm
I'm 100% with you there, there is absolutely no bad news here, financials are great! Acquistion is great we get revenue and get Aristotle in the market( keep in mind we aren't buying these guys unless we hit milestones the company has set that means test and money!), we will see all sorts of pieces before the AGM I'm almost sure of it This blood bath is a big fk you to James in my ...more  
Comment by Liked2Think on Apr 06, 2021 7:36pm
Ive had my not so great opinions of Tripp in the past but I was back on board big time. Thursday is unforgiveable to me though. For me to change my mind it will take an equivalent epic success as that rollout was an epic failure.  This company set itself back a year
Comment by Mermer2328 on Apr 06, 2021 7:38pm
Prove You wrong???really. The SP is all the proof I need!!
Comment by Mermer2328 on Apr 06, 2021 7:40pm
How about You prove yourself right and buy the ask , if it's so dirt cheap! That is after all, how the share price goes up
Comment by Northerencents on Apr 06, 2021 7:55pm
I've already made my arguments you however said jack shir factually fundamentally like I said prove me wrong bish
Comment by johnny007 on Apr 06, 2021 7:43pm
I explained the dissappointment in an earlier post. But again, the huge problem is that nobody wanted to deal with Aristotle _AND_ that they now also added a huge new cost factor just to try to sell Aristotle. This is a big game changer. It is like going from creating [, producing] and selling cakes to bakeries to become a state wide bakery chain with unforseen cost factors. And now ask ...more  
Comment by tineta on Apr 06, 2021 7:47pm
My advice to you. Sell your shares if have one, move on, don't wast your precious time here. Let's the believers stay here.
Comment by gojotv! on Apr 06, 2021 7:48pm
The 70% profit margin they've calculated looks good to me. If a new cost factor is going to be 30% of projected revenues, I'm great with that. But hey, thanks for ba-... uh, I mean, posting!
Comment by johnny007 on Apr 06, 2021 7:52pm
Of course, if they manage to produce such NET profit margins, i.e. operational profits before tax (EBITDA) .. then they would be gold. Hospitals hardly have such margins, so we have to see. Still - this would be no more really about Aristotle, but company reinventing themselves as a 'full featured' cancer clinic. Analysts and world needs to readjust perhaps, blink blink. OK, done here ...more  
Comment by Eagles1968 on Apr 06, 2021 9:27pm
Actually not true about the milestones. 15 million first then 8 if milestones are reached
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities